Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2013

Conditions
Inflammatory Bowel Disease (IBD)
Interventions
DRUG

Vaccine

MUTAGRIP (2009-2010 winter) VAXIGRIP (2010-2011 winter)

BIOLOGICAL

Vaccine anti-H1N1

patients who received the vaccine anti-H1N1

Trial Locations (1)

75014

CIC Vaccinologie Hopital Cochin, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

University of Paris 5 - Rene Descartes

OTHER

collaborator

Pierre and Marie Curie University

OTHER

collaborator

Institut Pasteur

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01022749 - Efficacy Safety Study of Flu Vaccine in Immunodepression Patients | Biotech Hunter | Biotech Hunter